董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Julie Bradley | 女 | Director | 51 | 未披露 | 未持股 | 2020-09-22 |
| Douglas Hirsch | 男 | Co-Chief Executive Officer and Director | 49 | 112.52万美元 | 未持股 | 2020-09-22 |
| Trevor Bezdek | 男 | Co-Chief Executive Officer and Director | 42 | 114.87万美元 | 未持股 | 2020-09-22 |
| Christopher Adams | 男 | Director | 41 | 未披露 | 未持股 | 2020-09-22 |
| Adam Karol | 男 | Director | 45 | 未披露 | 未持股 | 2020-09-22 |
| Jacqueline Kosecoff | 女 | Director | 71 | 2.00万美元 | 未持股 | 2020-09-22 |
| Stephen LeSieur | 男 | Director | 46 | 未披露 | 未持股 | 2020-09-22 |
| Gregory Mondre | 男 | Director | 46 | 未披露 | 未持股 | 2020-09-22 |
| Agnes Rey Giraud | 女 | Director | 56 | 2.00万美元 | 未持股 | 2020-09-22 |
| Dipanjan Deb | 男 | Director | 51 | 未披露 | 未持股 | 2020-09-22 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Bansi Nagji | 男 | President, Healthcare | 55 | 未披露 | 未持股 | 2020-09-22 |
| Douglas Hirsch | 男 | Co-Chief Executive Officer and Director | 49 | 112.52万美元 | 未持股 | 2020-09-22 |
| Trevor Bezdek | 男 | Co-Chief Executive Officer and Director | 42 | 114.87万美元 | 未持股 | 2020-09-22 |
| Andrew Slutsky | 男 | President, Consumer | 34 | 45.13万美元 | 未持股 | 2020-09-22 |
| Babak Azad | 男 | Chief Marketing Officer and SVP, Marketing & Communications | 47 | 22.03万美元 | 未持股 | 2020-09-22 |
| Bansi Nagji | 男 | President, Healthcare | 55 | 未披露 | 未持股 | 2020-09-22 |
| Karsten Voermann | 男 | Chief Financial Officer | 51 | 未披露 | 未持股 | 2020-09-22 |
董事简历
中英对照 | 中文 | 英文- Julie Bradley
-
Julie Bradley从2012年9月开始一直担任公司董事会董事。Bradley女士从2011年10月开始担任TripAdvisor, Inc.的首席财务官，这是一家在线旅行规划网站。在这之前，从2005年到2011年，她担任Art Technology Group, Inc.的首席财务官，这是一家电子商务软件公司；从2000年到2005年，担任阿卡迈科技公司（Akamai Technologies Inc.）的副总裁；从1993年到2000年，担任德勤会计师事务所（Deloitte & Touche LLP）的会计师。从2012年9月到2013年7月，Bradley女士担任ExactTarget, Inc.的董事。Bradley女士在威顿学院（Wheaton College）获得文学学士学位。
Julie Bradley has served as a member of our board of directors since September 2012. Ms. Bradley was the Chief Financial Officer of TripAdvisor, Inc., an online travel planning site, from October 2011 to November 2015. She previously served as the Chief Financial Officer of Art Technology Group, Inc., an ecommerce software company, from 2005 to 2011 the Vice President of Finance for Akamai Technologies, Inc. from 2000 to 2005 and an accountant at Deloitte & Touche LLP from 1993 to 2000. Ms. Bradley has served on the board of directors of Blue Apron, Inc. since September 2015 and previously served on the boards of Constant Contact, Inc. from June 2015 to February 2016 and ExactTarget, Inc. from September 2012 to July 2013. Ms. Bradley received a B.A. from Wheaton College. - Julie Bradley从2012年9月开始一直担任公司董事会董事。Bradley女士从2011年10月开始担任TripAdvisor, Inc.的首席财务官，这是一家在线旅行规划网站。在这之前，从2005年到2011年，她担任Art Technology Group, Inc.的首席财务官，这是一家电子商务软件公司；从2000年到2005年，担任阿卡迈科技公司（Akamai Technologies Inc.）的副总裁；从1993年到2000年，担任德勤会计师事务所（Deloitte & Touche LLP）的会计师。从2012年9月到2013年7月，Bradley女士担任ExactTarget, Inc.的董事。Bradley女士在威顿学院（Wheaton College）获得文学学士学位。
- Julie Bradley has served as a member of our board of directors since September 2012. Ms. Bradley was the Chief Financial Officer of TripAdvisor, Inc., an online travel planning site, from October 2011 to November 2015. She previously served as the Chief Financial Officer of Art Technology Group, Inc., an ecommerce software company, from 2005 to 2011 the Vice President of Finance for Akamai Technologies, Inc. from 2000 to 2005 and an accountant at Deloitte & Touche LLP from 1993 to 2000. Ms. Bradley has served on the board of directors of Blue Apron, Inc. since September 2015 and previously served on the boards of Constant Contact, Inc. from June 2015 to February 2016 and ExactTarget, Inc. from September 2012 to July 2013. Ms. Bradley received a B.A. from Wheaton College.
- Douglas Hirsch
-
Douglas Hirsch是我们的联合创始人之一，自2011年9月我们成立以来担任首席执行官和董事会成员。从2015年1月起，Hirsch先生担任我们的联合首席执行官。在我们成立之前，Hirsch先生担任DailyStrength，Inc.的首席执行官，该公司是一家专注于健康和福祉的社交网络。Hirsch先生是Yahoo！的早期员工，在那里他构思并管理最早的在线社区，包括GeoCities和Yahoo！之后，他担任雅虎娱乐（Yahoo！Entertainment）的总经理，之后成为Facebook的产品Vice President。Hirsch先生拥有Tufts University政治学学士学位。
Douglas Hirsch is one of our co-founders and has served as a Chief Executive Officer and as a member of our board of directors since our founding in September 2011. From January 2015 Mr. Hirsch served as our Co-Chief Executive Officer. Prior to our founding, Mr. Hirsch served as Chief Executive Officer at DailyStrength, Inc., a social network focused on health and wellness. Mr. Hirsch was an early employee at Yahoo!, where he conceived and managed the earliest online communities including GeoCities and Yahoo! Groups. He then served as the general manager of Yahoo! Entertainment, before moving on to becoming Vice President of Product at Facebook. Mr. Hirsch holds a B.A. in Political Science from Tufts University. - Douglas Hirsch是我们的联合创始人之一，自2011年9月我们成立以来担任首席执行官和董事会成员。从2015年1月起，Hirsch先生担任我们的联合首席执行官。在我们成立之前，Hirsch先生担任DailyStrength，Inc.的首席执行官，该公司是一家专注于健康和福祉的社交网络。Hirsch先生是Yahoo！的早期员工，在那里他构思并管理最早的在线社区，包括GeoCities和Yahoo！之后，他担任雅虎娱乐（Yahoo！Entertainment）的总经理，之后成为Facebook的产品Vice President。Hirsch先生拥有Tufts University政治学学士学位。
- Douglas Hirsch is one of our co-founders and has served as a Chief Executive Officer and as a member of our board of directors since our founding in September 2011. From January 2015 Mr. Hirsch served as our Co-Chief Executive Officer. Prior to our founding, Mr. Hirsch served as Chief Executive Officer at DailyStrength, Inc., a social network focused on health and wellness. Mr. Hirsch was an early employee at Yahoo!, where he conceived and managed the earliest online communities including GeoCities and Yahoo! Groups. He then served as the general manager of Yahoo! Entertainment, before moving on to becoming Vice President of Product at Facebook. Mr. Hirsch holds a B.A. in Political Science from Tufts University.
- Trevor Bezdek
-
Trevor Bezdek是我们的联合创始人之一，自2015年1月起担任我们的联合首席执行官，自2011年9月成立以来担任我们的董事会成员。Bezdek先生还担任我们两家全资子公司的总裁兼首席执行官。此前，Bezdek先生担任Tryarc，LLC的管理合伙人，该公司是一家技术公司，提供技术战略和实施服务，并共同创立了BioWire，为研究人员建立信息工具。Bezdek先生拥有斯坦福大学（Stanford University）的生物科学学士学位。
Trevor Bezdek is one of our co-founders and has served as our Co-Chief Executive Officer since January 2015 and as a member of our board of directors since our founding in September 2011. Mr. Bezdek also serves as President and Chief Executive Officer of two of our wholly-owned subsidiaries. Previously, Mr. Bezdek served as Managing Partner at Tryarc, LLC, a technology firm delivering technology strategy and implementation services, and co-founded Biowire, building information tools for researchers. Mr. Bezdek holds a B.S. in Biological Sciences from Stanford University. - Trevor Bezdek是我们的联合创始人之一，自2015年1月起担任我们的联合首席执行官，自2011年9月成立以来担任我们的董事会成员。Bezdek先生还担任我们两家全资子公司的总裁兼首席执行官。此前，Bezdek先生担任Tryarc，LLC的管理合伙人，该公司是一家技术公司，提供技术战略和实施服务，并共同创立了BioWire，为研究人员建立信息工具。Bezdek先生拥有斯坦福大学（Stanford University）的生物科学学士学位。
- Trevor Bezdek is one of our co-founders and has served as our Co-Chief Executive Officer since January 2015 and as a member of our board of directors since our founding in September 2011. Mr. Bezdek also serves as President and Chief Executive Officer of two of our wholly-owned subsidiaries. Previously, Mr. Bezdek served as Managing Partner at Tryarc, LLC, a technology firm delivering technology strategy and implementation services, and co-founded Biowire, building information tools for researchers. Mr. Bezdek holds a B.S. in Biological Sciences from Stanford University.
- Christopher Adams
-
Christopher Adams，2015年10月起，担任本公司董事。他是Francisco Partners Management，L.P.或Francisco Partners（私人股本公司）的合伙人（2008年8月以来）。在此之前，Adams先生是美国证券资本合伙公司（American Securities Capital Partners）的合伙人，这是一家私募股权公司，也是贝恩公司（Bain&Company）的管理顾问。Adams先生还在几家私人公司的董事会任职。Adams先生拥有乔治亚理工学院（Georgia Institute of Technology）的计算机工程学士学位和斯坦福大学商学院（Stanford Graduate School of Business）的工商管理硕士学位。
Christopher Adams has served as a member of our board of directors since October 2015. Mr. Adams is a Partner at Francisco Partners Management, L.P., or Francisco Partners, a private equity firm, where he has served since August 2008. Prior to this, Mr. Adams was an associate at American Securities Capital Partners, a private equity firm, and a management consultant at Bain & Company. Mr. Adams also serves on the board of directors of several private companies. Mr. Adams holds a B.S. in Computer Engineering from the Georgia Institute of Technology and an M.B.A. from the Stanford Graduate School of Business. - Christopher Adams，2015年10月起，担任本公司董事。他是Francisco Partners Management，L.P.或Francisco Partners（私人股本公司）的合伙人（2008年8月以来）。在此之前，Adams先生是美国证券资本合伙公司（American Securities Capital Partners）的合伙人，这是一家私募股权公司，也是贝恩公司（Bain&Company）的管理顾问。Adams先生还在几家私人公司的董事会任职。Adams先生拥有乔治亚理工学院（Georgia Institute of Technology）的计算机工程学士学位和斯坦福大学商学院（Stanford Graduate School of Business）的工商管理硕士学位。
- Christopher Adams has served as a member of our board of directors since October 2015. Mr. Adams is a Partner at Francisco Partners Management, L.P., or Francisco Partners, a private equity firm, where he has served since August 2008. Prior to this, Mr. Adams was an associate at American Securities Capital Partners, a private equity firm, and a management consultant at Bain & Company. Mr. Adams also serves on the board of directors of several private companies. Mr. Adams holds a B.S. in Computer Engineering from the Georgia Institute of Technology and an M.B.A. from the Stanford Graduate School of Business.
- Adam Karol
-
Adam Karol自2018年10月起担任我们的董事会成员。Karol先生是Silver Lake的常务董事。他于2009年加入银湖，担任校长，然后于2013年至2018年12月担任董事。任职Silver Lake公司之前，Karol先生曾任职Silver Point Capital，L.P.（一家资产管理公司）和Perry Capital（一家多策略投资公司）。Karol先生在Mom，Inc.的董事会任职。Karol先生拥有波士顿学院（Boston College）的财务与管理信息系统学士学位和宾夕法尼亚大学沃顿商学院（Wharton School of the University of Pennsylvania）的工商管理硕士学位。
Adam Karol has served as a member of our board of directors since October 2018. Mr. Karol is a Managing Director at Silver Lake. He joined Silver Lake in 2009 as a Principal and then served as a Director from 2013 to December 2018. Prior to Silver Lake, Mr. Karol worked at Silver Point Capital, L.P., an asset management firm, and at Perry Capital, a multi-strategy investment firm. Mr. Karol serves on the board of directors for A Place for Mom, Inc. Mr. Karol holds a B.S. in Finance and Management Information Systems from Boston College and an M.B.A. from The Wharton School of the University of Pennsylvania. - Adam Karol自2018年10月起担任我们的董事会成员。Karol先生是Silver Lake的常务董事。他于2009年加入银湖，担任校长，然后于2013年至2018年12月担任董事。任职Silver Lake公司之前，Karol先生曾任职Silver Point Capital，L.P.（一家资产管理公司）和Perry Capital（一家多策略投资公司）。Karol先生在Mom，Inc.的董事会任职。Karol先生拥有波士顿学院（Boston College）的财务与管理信息系统学士学位和宾夕法尼亚大学沃顿商学院（Wharton School of the University of Pennsylvania）的工商管理硕士学位。
- Adam Karol has served as a member of our board of directors since October 2018. Mr. Karol is a Managing Director at Silver Lake. He joined Silver Lake in 2009 as a Principal and then served as a Director from 2013 to December 2018. Prior to Silver Lake, Mr. Karol worked at Silver Point Capital, L.P., an asset management firm, and at Perry Capital, a multi-strategy investment firm. Mr. Karol serves on the board of directors for A Place for Mom, Inc. Mr. Karol holds a B.S. in Finance and Management Information Systems from Boston College and an M.B.A. from The Wharton School of the University of Pennsylvania.
- Jacqueline Kosecoff
-
Jacqueline Kosecoff自2017年起担任董事会成员。Kosecoff博士是Moriah Partners的管理合伙人，也是Warburg Pincus的高级顾问。从2002年到2012年，她曾担任UnitedHealth Group-Pacificare公司（她于2005年作为Pacificare Health Systems公司的收购的一部分加入该公司）的高级执行官，在那里她曾担任执行Vice President。加入UnitedHealth Group后，Kosecoff博士被任命为处方解决方案公司（现称为OptumRx）的首席执行官。在加入UnitedHealth Group-Pacificare之前，Kosecoff博士是ProtoCare的创始人，总裁兼首席运营官。目前Kosecoff博士担任这些上市公司的董事会成员:Steris，Trinet，Houlihan Lokey和Goodrx。Kosecoff博士还担任Sealed Air的董事会成员，但已通知公司，她将不会在2021年5月的年会上连任。2012年7月至2019年2月，Kosecoff博士担任Athenahealth，Inc.董事会成员Kosecoff博士拥有加州大学洛杉矶分校（University of California，Los Angeles）的学士学位，布朗大学（Brown University）的应用数学硕士学位，以及加州大学洛杉矶分校（University of California，Los Angeles）的博士学位。
Jacqueline Kosecoff has served as a member of our Board since 2017. Dr. Kosecoff is a Managing Partner of Moriah Partners and also a Senior Advisor of Warburg Pincus. From 2002 to 2012 Dr. Kosecoff was a senior executive inside UnitedHealth Group-PacifiCare, which she joined as part of the acquisition of PacifiCare Health Systems in 2005 where she served as Executive Vice President. Upon joining UnitedHealth Group, Dr. Kosecoff was appointed Chief Executive Officer of Prescription Solutions now known as OptumRx. Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and Chief Operating Officer of Protocare. Currently Dr. Kosecoff sits on the board of directors of these public companies: Steris, TriNet, Houlihan Lokey and GoodRx. Dr. Kosecoff also sits on the board of Sealed Air but has notified the company that she will not stand for re-election at the Annual Meeting in May 2021. From July 2012 through February 2019 Dr. Kosecoff served on the board of directors of athenahealth, Inc. Dr. Kosecoff holds a B.A. from the University of California, Los Angeles, an M.S. in Applied Mathematics from Brown University, and a doctorate from University of California, Los Angeles. - Jacqueline Kosecoff自2017年起担任董事会成员。Kosecoff博士是Moriah Partners的管理合伙人，也是Warburg Pincus的高级顾问。从2002年到2012年，她曾担任UnitedHealth Group-Pacificare公司（她于2005年作为Pacificare Health Systems公司的收购的一部分加入该公司）的高级执行官，在那里她曾担任执行Vice President。加入UnitedHealth Group后，Kosecoff博士被任命为处方解决方案公司（现称为OptumRx）的首席执行官。在加入UnitedHealth Group-Pacificare之前，Kosecoff博士是ProtoCare的创始人，总裁兼首席运营官。目前Kosecoff博士担任这些上市公司的董事会成员:Steris，Trinet，Houlihan Lokey和Goodrx。Kosecoff博士还担任Sealed Air的董事会成员，但已通知公司，她将不会在2021年5月的年会上连任。2012年7月至2019年2月，Kosecoff博士担任Athenahealth，Inc.董事会成员Kosecoff博士拥有加州大学洛杉矶分校（University of California，Los Angeles）的学士学位，布朗大学（Brown University）的应用数学硕士学位，以及加州大学洛杉矶分校（University of California，Los Angeles）的博士学位。
- Jacqueline Kosecoff has served as a member of our Board since 2017. Dr. Kosecoff is a Managing Partner of Moriah Partners and also a Senior Advisor of Warburg Pincus. From 2002 to 2012 Dr. Kosecoff was a senior executive inside UnitedHealth Group-PacifiCare, which she joined as part of the acquisition of PacifiCare Health Systems in 2005 where she served as Executive Vice President. Upon joining UnitedHealth Group, Dr. Kosecoff was appointed Chief Executive Officer of Prescription Solutions now known as OptumRx. Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and Chief Operating Officer of Protocare. Currently Dr. Kosecoff sits on the board of directors of these public companies: Steris, TriNet, Houlihan Lokey and GoodRx. Dr. Kosecoff also sits on the board of Sealed Air but has notified the company that she will not stand for re-election at the Annual Meeting in May 2021. From July 2012 through February 2019 Dr. Kosecoff served on the board of directors of athenahealth, Inc. Dr. Kosecoff holds a B.A. from the University of California, Los Angeles, an M.S. in Applied Mathematics from Brown University, and a doctorate from University of California, Los Angeles.
- Stephen LeSieur
-
Stephen Lesieur，2015年10月起，担任本公司董事。Lesieur先生是Spectrum Equity的常务董事，该公司是一家成长期私募股权公司，他自2005年以来一直在该公司任职，并共同领导该公司的梦百合技术投资工作。任职Spectrum公司之前，Lesieur先生曾担任Trident Capital公司的合伙人。Lesieur先生现在和过去都是几家私营梦百合和软件公司的董事。Lesieur先生拥有普林斯顿大学（Princeton University）经济学学士学位和达特茅斯学院（Dartmouth College）塔克商学院（Tuck School of Business）工商管理硕士学位。
Stephen LeSieur has served as a member of our board of directors since October 2015. Mr. LeSieur is a Managing Director at Spectrum Equity, a growth stage private equity firm, where he has served since 2005 and co-leads the firm’s healthcare technology investing efforts. Prior to Spectrum, Mr. LeSieur was an associate at Trident Capital. Mr. LeSieur serves and has served on the board of directors of several private healthcare and software companies. Mr. LeSieur holds a B.A. in Economics from Princeton University and an M.B.A. from the Tuck School of Business at Dartmouth College. - Stephen Lesieur，2015年10月起，担任本公司董事。Lesieur先生是Spectrum Equity的常务董事，该公司是一家成长期私募股权公司，他自2005年以来一直在该公司任职，并共同领导该公司的梦百合技术投资工作。任职Spectrum公司之前，Lesieur先生曾担任Trident Capital公司的合伙人。Lesieur先生现在和过去都是几家私营梦百合和软件公司的董事。Lesieur先生拥有普林斯顿大学（Princeton University）经济学学士学位和达特茅斯学院（Dartmouth College）塔克商学院（Tuck School of Business）工商管理硕士学位。
- Stephen LeSieur has served as a member of our board of directors since October 2015. Mr. LeSieur is a Managing Director at Spectrum Equity, a growth stage private equity firm, where he has served since 2005 and co-leads the firm’s healthcare technology investing efforts. Prior to Spectrum, Mr. LeSieur was an associate at Trident Capital. Mr. LeSieur serves and has served on the board of directors of several private healthcare and software companies. Mr. LeSieur holds a B.A. in Economics from Princeton University and an M.B.A. from the Tuck School of Business at Dartmouth College.
- Gregory Mondre
-
Gregory Mondre自2018年10月起担任我们的董事会成员。Mondre先生是Silver Lake的联合首席执行官。他于1999年加入Silver Lake，最近于2013年1月至2019年12月担任公司管理合伙人兼董事总经理。Mondre先生目前担任Expedia Group，Inc.（他自2020年5月起担任该职位）和Motorola Solutions（他自2015年8月起担任该职位）的董事会成员，他还担任审计，治理和提名委员会成员。他曾于2014年5月至2020年2月担任GodaddyInc.董事，并于2007年3月至2018年12月担任Sabre Corporation董事。Mondre先生拥有宾夕法尼亚大学沃顿商学院（Wharton School of the University of Pennsylvania）经济学B.S.学位。
Gregory Mondre has served as a member of our board of directors since October 2018. Mr. Mondre is Co-Chief Executive Officer at Silver Lake. He joined Silver Lake in 1999 and most recently served as a Managing Partner and Managing Director of the firm from January 2013 to December 2019. Mr. Mondre currently serves on the board of directors of Expedia Group, Inc., a position he has held since May 2020 and of Motorola Solutions, a position he has held since August 2015 and where he also serves on the Audit and Governance and Nominating Committees. He previously served as a director of GoDaddy Inc. from May 2014 to February 2020 and of Sabre Corporation from March 2007 to December 2018. Mr. Mondre holds a B.S. degree in Economics from The Wharton School of the University of Pennsylvania. - Gregory Mondre自2018年10月起担任我们的董事会成员。Mondre先生是Silver Lake的联合首席执行官。他于1999年加入Silver Lake，最近于2013年1月至2019年12月担任公司管理合伙人兼董事总经理。Mondre先生目前担任Expedia Group，Inc.（他自2020年5月起担任该职位）和Motorola Solutions（他自2015年8月起担任该职位）的董事会成员，他还担任审计，治理和提名委员会成员。他曾于2014年5月至2020年2月担任GodaddyInc.董事，并于2007年3月至2018年12月担任Sabre Corporation董事。Mondre先生拥有宾夕法尼亚大学沃顿商学院（Wharton School of the University of Pennsylvania）经济学B.S.学位。
- Gregory Mondre has served as a member of our board of directors since October 2018. Mr. Mondre is Co-Chief Executive Officer at Silver Lake. He joined Silver Lake in 1999 and most recently served as a Managing Partner and Managing Director of the firm from January 2013 to December 2019. Mr. Mondre currently serves on the board of directors of Expedia Group, Inc., a position he has held since May 2020 and of Motorola Solutions, a position he has held since August 2015 and where he also serves on the Audit and Governance and Nominating Committees. He previously served as a director of GoDaddy Inc. from May 2014 to February 2020 and of Sabre Corporation from March 2007 to December 2018. Mr. Mondre holds a B.S. degree in Economics from The Wharton School of the University of Pennsylvania.
- Agnes Rey Giraud
-
Agnes Rey Giraud于2021年6月完成业务合并后加入Uphealth，Inc.董事会。Rey-Giraud女士是Acera Surgical，Inc.的董事长，她于2013年与他人共同创立了Acera Surgical，Inc.，并在2022年5月之前担任该公司的首席执行官。Acera Surgical公司设计了一种新型的可吸收合成混合尺度纤维基质，旨在修复受损组织。Rey-Giraud女士之前是Express Scripts控股公司Nasdaq：ESRX的一名高级职员，该公司是一家财富100强公司，在该公司担任多个行政职务，包括产品开发、供应链、公司战略执行副总裁和国际运营总裁，职责日益增加。Rey-Giraud女士目前担任GoodRx，Inc.（纳斯达克股票代码：GDRX）的董事会成员，自2016年起担任该职务。该公司最近完成了一项价值数十亿美元的IPO IPO。GoodRx提供一系列服务，帮助人们以负担得起的价格获得所需的医疗保健。此外，Rey-Giraud女士还曾在多个董事会任职，包括从2000年到2006年设计和创立的医疗保健技术服务公司RxHub（现为SureScripts）。在此期间，RxHub从一个商业计划转变为一个服务和技术平台，促进了通信标准的制定和电子处方在美国的采用，而电子处方现在已成为该国的共同标准。她的其他董事会职务包括2011年9月至2020年6月的健康公司Pritikin和2013年9月至2015年3月的私人药品批发经销商HD Smith。Rey-Giraud女士是一名癌症幸存者，她将挽救生命的治疗归功于一项临床试验。此后，她一直倡导提高对乳腺癌的认识和负担得起的医疗保健，特别是对诊断为衰弱或绝症的患者。Rey-Giraud女士拥有芝加哥大学工商管理硕士学位、里昂商学院运营管理硕士学位以及同样在法国获得的工程学硕士学位。她曾获得西北大学和哈佛学院的董事会服务证书。
Agnes Rey Giraud joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Ms. Rey-Giraud is Chairman of Acera Surgical, Inc., which she co-founded in 2013 and until May 2022 was its Chief Executive Officer. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. Ms. Rey-Giraud was previously an officer at Express Scripts Holding Company Nasdaq: ESRX, a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including Executive Vice President of Product Development, Supply Chain, Corporate Strategy and President of International Operations. Ms. Rey-Giraud currently serves on the board of GoodRx, Inc. (Nasdaq: GDRX), a role she has held since 2016. The company recently completed a multibillion IPO. GoodRx offers a range of services that help people get the healthcare they need at a price they can afford. In addition, Ms. Rey-Giraud has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation from 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the United States that are now the common standard in the country. Her other board roles have included Pritikin, a wellness company, from September 2011 to June 2020 and HD Smith, a privately owned drug wholesale distributor, from September 2013 to March 2015. Ms. Rey-Giraud is a cancer survivor who credits a clinical trial with her life-saving treatment. She has since become an advocate for breast cancer awareness and affordable health care, especially for patients diagnosed with debilitating or terminal illness. Ms. Rey-Giraud holds an MBA from the University of Chicago, a Master of Management in Operations from Ecole de Management de Lyon Business School, and a Master's Degree in engineering, also earned in France. She has earned certifications in board service from Northwestern University and Harvard College. - Agnes Rey Giraud于2021年6月完成业务合并后加入Uphealth，Inc.董事会。Rey-Giraud女士是Acera Surgical，Inc.的董事长，她于2013年与他人共同创立了Acera Surgical，Inc.，并在2022年5月之前担任该公司的首席执行官。Acera Surgical公司设计了一种新型的可吸收合成混合尺度纤维基质，旨在修复受损组织。Rey-Giraud女士之前是Express Scripts控股公司Nasdaq：ESRX的一名高级职员，该公司是一家财富100强公司，在该公司担任多个行政职务，包括产品开发、供应链、公司战略执行副总裁和国际运营总裁，职责日益增加。Rey-Giraud女士目前担任GoodRx，Inc.（纳斯达克股票代码：GDRX）的董事会成员，自2016年起担任该职务。该公司最近完成了一项价值数十亿美元的IPO IPO。GoodRx提供一系列服务，帮助人们以负担得起的价格获得所需的医疗保健。此外，Rey-Giraud女士还曾在多个董事会任职，包括从2000年到2006年设计和创立的医疗保健技术服务公司RxHub（现为SureScripts）。在此期间，RxHub从一个商业计划转变为一个服务和技术平台，促进了通信标准的制定和电子处方在美国的采用，而电子处方现在已成为该国的共同标准。她的其他董事会职务包括2011年9月至2020年6月的健康公司Pritikin和2013年9月至2015年3月的私人药品批发经销商HD Smith。Rey-Giraud女士是一名癌症幸存者，她将挽救生命的治疗归功于一项临床试验。此后，她一直倡导提高对乳腺癌的认识和负担得起的医疗保健，特别是对诊断为衰弱或绝症的患者。Rey-Giraud女士拥有芝加哥大学工商管理硕士学位、里昂商学院运营管理硕士学位以及同样在法国获得的工程学硕士学位。她曾获得西北大学和哈佛学院的董事会服务证书。
- Agnes Rey Giraud joined Uphealth, Inc.'s Board upon the closing of the Business Combinations in June 2021. Ms. Rey-Giraud is Chairman of Acera Surgical, Inc., which she co-founded in 2013 and until May 2022 was its Chief Executive Officer. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. Ms. Rey-Giraud was previously an officer at Express Scripts Holding Company Nasdaq: ESRX, a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including Executive Vice President of Product Development, Supply Chain, Corporate Strategy and President of International Operations. Ms. Rey-Giraud currently serves on the board of GoodRx, Inc. (Nasdaq: GDRX), a role she has held since 2016. The company recently completed a multibillion IPO. GoodRx offers a range of services that help people get the healthcare they need at a price they can afford. In addition, Ms. Rey-Giraud has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation from 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the United States that are now the common standard in the country. Her other board roles have included Pritikin, a wellness company, from September 2011 to June 2020 and HD Smith, a privately owned drug wholesale distributor, from September 2013 to March 2015. Ms. Rey-Giraud is a cancer survivor who credits a clinical trial with her life-saving treatment. She has since become an advocate for breast cancer awareness and affordable health care, especially for patients diagnosed with debilitating or terminal illness. Ms. Rey-Giraud holds an MBA from the University of Chicago, a Master of Management in Operations from Ecole de Management de Lyon Business School, and a Master's Degree in engineering, also earned in France. She has earned certifications in board service from Northwestern University and Harvard College.
- Dipanjan Deb
-
Dipanjan Deb，他一直担任我们的董事（2013年10月以来）。他曾共同创立Francisco Partners公司（私人股本公司），并一直担任合伙人（1999年8月创立以来），也曾一直担任执行合伙人（2005年8月以来）。共同创立Francisco Partners公司之前，他曾任职TPG Capital公司（私人股本公司）、麦肯锡咨询公司（McKinsey & Company，管理主席公司）、Robertson, Stephens & Company（以技术为主的投资银行）。他目前服务于众多私营公司的董事会。他持有加州大学伯克利分校（the University of California, Berkeley）的电气工程和计算机科学的学士学位，以及斯坦福大学商学院 （ Stanford Graduate School of Business ）的工商管理硕士学位。
Dipanjan Deb has served as a member of our board of directors since October 2015. Mr. Deb is a founder of Francisco Partners and has served as the Managing Partner/Chief Executive Officer of Francisco Partners since September 2005. Mr. Deb has also served as a Partner of Francisco Partners since its founding in August 1999. Prior to founding Francisco Partners, Mr. Deb was a principal at TPG Capital, a private equity firm, a Director of Semiconductor Banking at Robertson, Stephens & Company and a management consultant at McKinsey & Company. Mr. Deb has served on the board of directors of numerous public companies including most recently Ichor Systems, Inc. from February 2012 to May 2018 and currently serves on the board of directors of several private companies. Mr. Deb holds a B.S. in Electrical Engineering and Computer Science from the University of California, Berkeley and an M.B.A. from the Stanford Graduate School of Business. - Dipanjan Deb，他一直担任我们的董事（2013年10月以来）。他曾共同创立Francisco Partners公司（私人股本公司），并一直担任合伙人（1999年8月创立以来），也曾一直担任执行合伙人（2005年8月以来）。共同创立Francisco Partners公司之前，他曾任职TPG Capital公司（私人股本公司）、麦肯锡咨询公司（McKinsey & Company，管理主席公司）、Robertson, Stephens & Company（以技术为主的投资银行）。他目前服务于众多私营公司的董事会。他持有加州大学伯克利分校（the University of California, Berkeley）的电气工程和计算机科学的学士学位，以及斯坦福大学商学院 （ Stanford Graduate School of Business ）的工商管理硕士学位。
- Dipanjan Deb has served as a member of our board of directors since October 2015. Mr. Deb is a founder of Francisco Partners and has served as the Managing Partner/Chief Executive Officer of Francisco Partners since September 2005. Mr. Deb has also served as a Partner of Francisco Partners since its founding in August 1999. Prior to founding Francisco Partners, Mr. Deb was a principal at TPG Capital, a private equity firm, a Director of Semiconductor Banking at Robertson, Stephens & Company and a management consultant at McKinsey & Company. Mr. Deb has served on the board of directors of numerous public companies including most recently Ichor Systems, Inc. from February 2012 to May 2018 and currently serves on the board of directors of several private companies. Mr. Deb holds a B.S. in Electrical Engineering and Computer Science from the University of California, Berkeley and an M.B.A. from the Stanford Graduate School of Business.
高管简历
中英对照 | 中文 | 英文- Bansi Nagji
Bansi Nagji自2020年6月以来，一直担任我们的医疗保健总裁。Nagji先生此前曾在McKesson Corporation担任执行副总裁兼首席战略和业务发展官超过5年，McKesson Corporation是医疗保健供应链管理解决方案和零售药房的全球领导者。在加入McKesson Corporation之前，Nagji先生于2013年1月至2015年2月担任咨询公司Deloitte Consulting，LLP的负责人以及Monitor Monitor的全球负责人。Nagji先生先前在全球战略咨询公司Monitor Group工作了近20年，并在与Deloitte合并后担任该公司的高级合伙人兼总裁。Nagji先生目前是Change Healthcare，Inc。的董事会成员，他还是薪酬委员会，提名和公司治理委员会的成员。他曾在2013年至2015年期间担任包括Deloitte LLP在内的多家私人公司的董事。Nagji先生获得剑桥大学的学士学位和硕士学位以及欧洲工商管理学院的工商管理硕士学位。
Bansi Nagji has served as our President, Healthcare since June 2020. Previously, Mr. Nagji served for more than 5 years as the Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation, a global leader in healthcare supply chain management solutions and retail pharmacy. Prior to McKesson Corporation, Mr. Nagji served from January 2013 to February 2015 as a Principal of Deloitte Consulting, LLP, a consulting firm, and as the Global Leader of Monitor Deloitte. Mr. Nagji previously worked for almost 20 years at Monitor Group, a global strategy consulting firm, and served as a senior partner and President of the firm when it merged with Deloitte. Currently, Mr. Nagji serves on the board of directors of Change Healthcare, Inc., where he also sits on the Compensation Committee and Nominating and Corporate Governance Committee. He has previously served as a director of several private companies, including Deloitte LLP from 2013 to 2015. Mr. Nagji received B.A. and M.A. degrees from Cambridge University and an M.B.A. with Distinction from INSEAD.- Bansi Nagji自2020年6月以来，一直担任我们的医疗保健总裁。Nagji先生此前曾在McKesson Corporation担任执行副总裁兼首席战略和业务发展官超过5年，McKesson Corporation是医疗保健供应链管理解决方案和零售药房的全球领导者。在加入McKesson Corporation之前，Nagji先生于2013年1月至2015年2月担任咨询公司Deloitte Consulting，LLP的负责人以及Monitor Monitor的全球负责人。Nagji先生先前在全球战略咨询公司Monitor Group工作了近20年，并在与Deloitte合并后担任该公司的高级合伙人兼总裁。Nagji先生目前是Change Healthcare，Inc。的董事会成员，他还是薪酬委员会，提名和公司治理委员会的成员。他曾在2013年至2015年期间担任包括Deloitte LLP在内的多家私人公司的董事。Nagji先生获得剑桥大学的学士学位和硕士学位以及欧洲工商管理学院的工商管理硕士学位。
- Bansi Nagji has served as our President, Healthcare since June 2020. Previously, Mr. Nagji served for more than 5 years as the Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation, a global leader in healthcare supply chain management solutions and retail pharmacy. Prior to McKesson Corporation, Mr. Nagji served from January 2013 to February 2015 as a Principal of Deloitte Consulting, LLP, a consulting firm, and as the Global Leader of Monitor Deloitte. Mr. Nagji previously worked for almost 20 years at Monitor Group, a global strategy consulting firm, and served as a senior partner and President of the firm when it merged with Deloitte. Currently, Mr. Nagji serves on the board of directors of Change Healthcare, Inc., where he also sits on the Compensation Committee and Nominating and Corporate Governance Committee. He has previously served as a director of several private companies, including Deloitte LLP from 2013 to 2015. Mr. Nagji received B.A. and M.A. degrees from Cambridge University and an M.B.A. with Distinction from INSEAD.
- Douglas Hirsch
Douglas Hirsch是我们的联合创始人之一，自2011年9月我们成立以来担任首席执行官和董事会成员。从2015年1月起，Hirsch先生担任我们的联合首席执行官。在我们成立之前，Hirsch先生担任DailyStrength，Inc.的首席执行官，该公司是一家专注于健康和福祉的社交网络。Hirsch先生是Yahoo！的早期员工，在那里他构思并管理最早的在线社区，包括GeoCities和Yahoo！之后，他担任雅虎娱乐（Yahoo！Entertainment）的总经理，之后成为Facebook的产品Vice President。Hirsch先生拥有Tufts University政治学学士学位。
Douglas Hirsch is one of our co-founders and has served as a Chief Executive Officer and as a member of our board of directors since our founding in September 2011. From January 2015 Mr. Hirsch served as our Co-Chief Executive Officer. Prior to our founding, Mr. Hirsch served as Chief Executive Officer at DailyStrength, Inc., a social network focused on health and wellness. Mr. Hirsch was an early employee at Yahoo!, where he conceived and managed the earliest online communities including GeoCities and Yahoo! Groups. He then served as the general manager of Yahoo! Entertainment, before moving on to becoming Vice President of Product at Facebook. Mr. Hirsch holds a B.A. in Political Science from Tufts University.- Douglas Hirsch是我们的联合创始人之一，自2011年9月我们成立以来担任首席执行官和董事会成员。从2015年1月起，Hirsch先生担任我们的联合首席执行官。在我们成立之前，Hirsch先生担任DailyStrength，Inc.的首席执行官，该公司是一家专注于健康和福祉的社交网络。Hirsch先生是Yahoo！的早期员工，在那里他构思并管理最早的在线社区，包括GeoCities和Yahoo！之后，他担任雅虎娱乐（Yahoo！Entertainment）的总经理，之后成为Facebook的产品Vice President。Hirsch先生拥有Tufts University政治学学士学位。
- Douglas Hirsch is one of our co-founders and has served as a Chief Executive Officer and as a member of our board of directors since our founding in September 2011. From January 2015 Mr. Hirsch served as our Co-Chief Executive Officer. Prior to our founding, Mr. Hirsch served as Chief Executive Officer at DailyStrength, Inc., a social network focused on health and wellness. Mr. Hirsch was an early employee at Yahoo!, where he conceived and managed the earliest online communities including GeoCities and Yahoo! Groups. He then served as the general manager of Yahoo! Entertainment, before moving on to becoming Vice President of Product at Facebook. Mr. Hirsch holds a B.A. in Political Science from Tufts University.
- Trevor Bezdek
Trevor Bezdek是我们的联合创始人之一，自2015年1月起担任我们的联合首席执行官，自2011年9月成立以来担任我们的董事会成员。Bezdek先生还担任我们两家全资子公司的总裁兼首席执行官。此前，Bezdek先生担任Tryarc，LLC的管理合伙人，该公司是一家技术公司，提供技术战略和实施服务，并共同创立了BioWire，为研究人员建立信息工具。Bezdek先生拥有斯坦福大学（Stanford University）的生物科学学士学位。
Trevor Bezdek is one of our co-founders and has served as our Co-Chief Executive Officer since January 2015 and as a member of our board of directors since our founding in September 2011. Mr. Bezdek also serves as President and Chief Executive Officer of two of our wholly-owned subsidiaries. Previously, Mr. Bezdek served as Managing Partner at Tryarc, LLC, a technology firm delivering technology strategy and implementation services, and co-founded Biowire, building information tools for researchers. Mr. Bezdek holds a B.S. in Biological Sciences from Stanford University.- Trevor Bezdek是我们的联合创始人之一，自2015年1月起担任我们的联合首席执行官，自2011年9月成立以来担任我们的董事会成员。Bezdek先生还担任我们两家全资子公司的总裁兼首席执行官。此前，Bezdek先生担任Tryarc，LLC的管理合伙人，该公司是一家技术公司，提供技术战略和实施服务，并共同创立了BioWire，为研究人员建立信息工具。Bezdek先生拥有斯坦福大学（Stanford University）的生物科学学士学位。
- Trevor Bezdek is one of our co-founders and has served as our Co-Chief Executive Officer since January 2015 and as a member of our board of directors since our founding in September 2011. Mr. Bezdek also serves as President and Chief Executive Officer of two of our wholly-owned subsidiaries. Previously, Mr. Bezdek served as Managing Partner at Tryarc, LLC, a technology firm delivering technology strategy and implementation services, and co-founded Biowire, building information tools for researchers. Mr. Bezdek holds a B.S. in Biological Sciences from Stanford University.
- Andrew Slutsky
Andrew Slutsky自2019年10月起担任我们的消费者总裁，自2012年2月起在公司任职，是我们的第三名员工。Slutsky从2011年到2012年担任Renttherunway（一家互联网服装公司）高级营销经理，从2008年到2011年担任Loeb Enterprises（一家风险投资公司）董事，在那里他为Loeb Enterprises’；早期药房折扣计划推出数字营销。Slutsky先生拥有Amherst College政治学学士学位。
Andrew Slutsky has served as our President, Consumer since October 2019 and has been at the Company since February 2012 and was our third employee. From 2011 to 2012 Mr. Slutsky served as a Senior Marketing Manager at RentTheRunway, an internet clothing company, and from 2008 to 2011 Mr. Slutsky served as a Director of Loeb Enterprises, a venture capital company, where he launched digital marketing for Loeb Enterprises’ early pharmacy discount program. Mr. Slutsky holds a B.A. in Political Science from Amherst College.- Andrew Slutsky自2019年10月起担任我们的消费者总裁，自2012年2月起在公司任职，是我们的第三名员工。Slutsky从2011年到2012年担任Renttherunway（一家互联网服装公司）高级营销经理，从2008年到2011年担任Loeb Enterprises（一家风险投资公司）董事，在那里他为Loeb Enterprises’；早期药房折扣计划推出数字营销。Slutsky先生拥有Amherst College政治学学士学位。
- Andrew Slutsky has served as our President, Consumer since October 2019 and has been at the Company since February 2012 and was our third employee. From 2011 to 2012 Mr. Slutsky served as a Senior Marketing Manager at RentTheRunway, an internet clothing company, and from 2008 to 2011 Mr. Slutsky served as a Director of Loeb Enterprises, a venture capital company, where he launched digital marketing for Loeb Enterprises’ early pharmacy discount program. Mr. Slutsky holds a B.A. in Political Science from Amherst College.
- Babak Azad
Babak Azad自2019年10月起担任我们的首席营销官兼营销与传播高级副总裁。Azad先生是营销咨询业务Round2Ventures，LLC的创始人，专注于各种客户的营销活动，包括2017年6月至2019年10月的GoodRx。在此之前，Azad从2007年2月到2015年4月担任Beachbody，LLC（一家健康和健身相关产品开发商）媒体和客户获取高级副总裁。Azad先生拥有MIT数学学士学位和Stanford Graduate School of Business工商管理硕士学位。
Babak Azad has served as our Chief Marketing Officer and SVP, Marketing & Communications since October 2019. Mr. Azad is the Founder of Round 2 Ventures, LLC, a marketing consulting business, focused on marketing activities of various clients, including GoodRx from June 2017 to October 2019. Prior to this, Mr. Azad served as a Senior Vice President of Media and Customer Acquisition for Beachbody, LLC, a developer of health and fitness related products, from February 2007 to April 2015. Mr. Azad holds a B.S. in Mathematics from MIT and an M.B.A. from the Stanford Graduate School of Business.- Babak Azad自2019年10月起担任我们的首席营销官兼营销与传播高级副总裁。Azad先生是营销咨询业务Round2Ventures，LLC的创始人，专注于各种客户的营销活动，包括2017年6月至2019年10月的GoodRx。在此之前，Azad从2007年2月到2015年4月担任Beachbody，LLC（一家健康和健身相关产品开发商）媒体和客户获取高级副总裁。Azad先生拥有MIT数学学士学位和Stanford Graduate School of Business工商管理硕士学位。
- Babak Azad has served as our Chief Marketing Officer and SVP, Marketing & Communications since October 2019. Mr. Azad is the Founder of Round 2 Ventures, LLC, a marketing consulting business, focused on marketing activities of various clients, including GoodRx from June 2017 to October 2019. Prior to this, Mr. Azad served as a Senior Vice President of Media and Customer Acquisition for Beachbody, LLC, a developer of health and fitness related products, from February 2007 to April 2015. Mr. Azad holds a B.S. in Mathematics from MIT and an M.B.A. from the Stanford Graduate School of Business.
- Bansi Nagji
- 暂无中文简介
Bansi Nagji has served as our President, Healthcare since June 2020. Previously, Mr. Nagji served for more than 5 years as the Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation, a global leader in healthcare supply chain management solutions and retail pharmacy. Prior to McKesson Corporation, Mr. Nagji served from January 2013 to February 2015 as a Principal of Deloitte Consulting, LLP, a consulting firm, and as the Global Leader of Monitor Deloitte. Mr. Nagji previously worked for almost 20 years at Monitor Group, a global strategy consulting firm, and served as a senior partner and President of the firm when it merged with Deloitte. Currently, Mr. Nagji serves on the board of directors of Change Healthcare, Inc., where he also sits on the Compensation Committee and Nominating and Corporate Governance Committee. He has previously served as a director of several private companies, including Deloitte LLP from 2013 to 2015. Mr. Nagji received B.A. and M.A. degrees from Cambridge University and an M.B.A. with Distinction from INSEAD. - 暂无中文简介
- Bansi Nagji has served as our President, Healthcare since June 2020. Previously, Mr. Nagji served for more than 5 years as the Executive Vice President and Chief Strategy and Business Development Officer at McKesson Corporation, a global leader in healthcare supply chain management solutions and retail pharmacy. Prior to McKesson Corporation, Mr. Nagji served from January 2013 to February 2015 as a Principal of Deloitte Consulting, LLP, a consulting firm, and as the Global Leader of Monitor Deloitte. Mr. Nagji previously worked for almost 20 years at Monitor Group, a global strategy consulting firm, and served as a senior partner and President of the firm when it merged with Deloitte. Currently, Mr. Nagji serves on the board of directors of Change Healthcare, Inc., where he also sits on the Compensation Committee and Nominating and Corporate Governance Committee. He has previously served as a director of several private companies, including Deloitte LLP from 2013 to 2015. Mr. Nagji received B.A. and M.A. degrees from Cambridge University and an M.B.A. with Distinction from INSEAD.
- Karsten Voermann
- 暂无中文简介
Karsten Voermann has served as our Chief Financial Officer since March 2020. From May 2018 to February 2020 Mr. Voermann served as Chief Financial Officer of Mercer Advisors, an investment advisory services firm, and from July 2015 to May 2018 Mr. Voermann served as Chief Financial Officer of Ibotta, an app-based provider of consumer discounts on consumer packaged goods and other items. Mr. Voermann holds an H.B.A. in Business from the University of Western Ontario and an M.B.A. from Harvard Business School. - 暂无中文简介
- Karsten Voermann has served as our Chief Financial Officer since March 2020. From May 2018 to February 2020 Mr. Voermann served as Chief Financial Officer of Mercer Advisors, an investment advisory services firm, and from July 2015 to May 2018 Mr. Voermann served as Chief Financial Officer of Ibotta, an app-based provider of consumer discounts on consumer packaged goods and other items. Mr. Voermann holds an H.B.A. in Business from the University of Western Ontario and an M.B.A. from Harvard Business School.